Similar to previous reports, the presence of the proteasome inhibitor MG132 blocked TWIST1 degradation in all ovarian cancer cells, primarily in primary EOC cells that did not express TWIST1 (Fig. 2a). This evidence concerns the gene TWIST1 and ovarian carcinoma.